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Single rat hcpatocytes microinjected with aequorin show free Ca oscillations when stimulated with Ca” -mobilizing hormones. WC show here that 
an inhibitor of diacylgiycerol kinase (R 59 022) and an analoguc of native diacylglycerol (diC& inhibit fret Ca oscillations inducxxl by pircnylephrinc 
and vasopressin. These results agree with a negative feedback c&xl of protein kinase C on free Ca oscil!ations. 
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1. INTRODUCTION 
Diacylglycerol (DG), an intermediate in the biosyn- 
thesis and degradation of glycerolipids in eukaryotic 
cells, has been demonstrated to play an important role 
as an intracellular second messenger, in particular in 
activating protein kinase C (PK.) [l]. DG may be 
formed by several pathways, the best characterized of 
which is the hydrolysis of phosphatidyl inositol 4,5- 
bisphosphate to DG and inositol 1,4,5-trisphosphate 
catalysed by a specific phospholipase C [2]. DG can also 
be formed by breakdown of phosphatidyl choline, by 
another phospholipase C [3]. The degradation of a 
phosphatidyl inositol-glycan could be a third source of 
DG [4]. Rapid removal of DG is required to terminate 
the response to agonists, and to reset the system for 
subsequent signalling events. DG attenuation may 
occur by two pathways. DG can be phosphorylated by 
DG-kinase to phosphatidic acid: this is the predominant 
route [S]. Alternatively, DG may be degraded by DG- 
lipase [6]. 
Ca2+-mobilizing agonists, which are mediated by 
inositol 1,4,5-trisphosphate, induce free Ca?’ osciila- 
tions (spikes) in single hepatocytes [7]. While the fre- 
quency of oscillations depends on agonist dose, the 
time-course of an individual spike does not change with 
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agonist concentration for a giver1 agonist 181. The fre- 
quency of spiking is depressed by phorbol ester activa- 
tion of PMC [9], while inhibitors of PKC prolong the 
falling phase of each spike [IO]. Here we show the effect 
on free Ca oscillations of perturbing DG metabolism 
using a DG-kicase inhibitor, R 59 022, which has been 
shown to raise DG levels in platelets [ll] and hepato- 
cytes [12], and a DG analogue, diCs. 
2. MATERIALS AND METHODS 
Hepatocytcs were isolated from fed, 150-250 6. male Wiscar ats by 
collagcnase perfusion as described previously [13]. Microinjection 01 
single hepalocytes with acquorin, and data acquisition, hnvc been 
previously dcscribcd [l4]. The izxi;cl;r;cntal medium was Williams’ 
Medium E (Flow Laboratories) gassed with CO$ir (1:19) at 37OC. 
All substances were added to this medium. The DG-kinasc inhibitor. 
R 59 022, was from Janssm Pharmaceutical; nd diC8, phcnylephrine 
and vasoprcssin were from Sigma. Statistical significance: was calcu- 
lated by Student’s I-test. 
3. RESULTS 
Fig. 1 shows the effect of R 59 022 on phenylephrine- 
induced spikes; R 59 022 (0.1 yM) reversibly reduced 
the frequency, and peak free Ca, of phenylephrine-in- 
duced spikes (Fig la; representative of 7 hepatocytes 
exposed to concentrations of R 59 022 between 2-500 
nM). These effects of R 59 022 are detailed in Table I 
where data from spikes from 4 hepatocytes whose free 
Ca oscillations howed similar frequency and peak free 
Ca in response to phenylephrine (1 PM for 3 hepato- 
cytes and 0.6~M for 1 hepatocyte). The period between 
spikes showed a ca. 2.5-fold increase, while peak free Ca 
shows a small but significant (P < 0.01) decrease. Nei- 
ther the duration of the spikes nor the time constant oi 
the falling phase of the spikes are afl’scted (Table 1). 
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Fig. I. Two different hepatocytcs were microinjected with acquorin and superfused at the times indicated with (a) 0.1 yM R 59 022 and 1 YM 
phenylrphrinc (Phe), and (b) 1 ,uM R 59 022 and 0.6 ,u~I phenylsphrinc (Phe). The time constant for the resting concentration of free Ca was IO 
s, and for oscillations I s. 
Higher concentrations of R 59 022 (1 ,uM) blocked the 
spikes induced by phenylephrine, usually irreversibly 
(Fig. 1 b; representative of 7 hepatocytes at concentra- 
tions of R 59 022 between 0.05-15 PM. In only one of 
these 7 hepatocytes was the effect of R 59 022 reversi- 
ble). 
High concentrations of R 59 022 (10 ,uM), sufficient 
to completely abolish phenylephrine-induced spikes, ei- 
ther reduce the frequency of free ca oscillations induced 
by OS nM vasopressin (Fig. 2, representative of 4 hena- 
cocytes), or completely .ibolished spiking (3 hepato- 
cytes; in two of them these ffects were irreversible, data 
not shown). The minimum concentration of the TX- 
kinase inhibitor, R 59 022, needed to affect oscillations 
induced by vasopressin was ca, 1 PM, compared with 
0.1 AM for phenyIephrine r sponses. 
Anolher way to increase DO levels in the cell is by 
adding DG onalogues uch as diCB, which is permeant 
to the cell membrane [15]. Fig. 3a shows the effect of 
diCs on free Ca oscillations induced by 1 @T phr:nyle- 
Table I 
Effect of 0.1 PM R 59 022 on the characteristics of the free Ca 
oscillations induced by phenylcphrine 
Treatment R Peak Period be- Length Falling time 
free Ca tween oscilla- (s) constant (s) 
(W tions (5) 
Phenylc- 60 128 f 12 37.54 zb I .79 5.1 * 0.52 3.06 z? 0.1 
phrine 
Phcnyle- 25 653 k 21* 56.45 r 23.34*” 4.99 & 0.54 3.91 z 0.98 
phrinc + 
R 59 022 
The results how the means _” S.E,M. for a number (II) of oscillations. 
“P < 0.01; ““P c 0.001. 
phrine. At 10 ,uM diC, the frequency of the oscillations 
is slightly reduced, but an increase in the diC, concen- 
tration to 1 S yM reversibly blocked the free Ca oscilla- 
tions (Fig. 3a). diCs at concentrations of lo-25 ,uM 
either reduced the frequency of the oscillations induced 
by phenylephrine without any effect on other spikes 
characteristics (5out of 11 hepatocytes), or completely 
blocked the oscillations (6 out of 11 hepatocytes). In
only two of these 6 hepatocytes was the blockade irre- 
versible (data not shown); in the other 4 the oscillations 
reccxvered, but with a lower frequency and a slight re- 
duction in peak free Ca (Fig. 3a). Fig. 3b shows that 20 
,uM diC, reduced the frequency and peak free Ca of the 
oscillations induced by 0.25 nM vasopressin (7 hepalo- 
cytes). In 2 of these 7 hepatocytes the effect on frc- 
quency was not reversible, while the effect on peak free 
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Fig. 2, Effect of 10 ,uM R 59 022 on free Ca oscillations induced by 
0.5 nM vnsopressin (VP). The time constants and other details were 
as in Fig. 1. 
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Fig. 3. Effect of (a) 10 and 15 PM diC8 on free Ca oscillations induced by I PM phenylephrinc (Phe). and (b) 20 PM diC, on fm Ca otillatione 
induced by 0.25 nM vasopressin (VP). The time constants and other details were as in Fig. I. 
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Ca was always reversible (data not shown). In a further 
3 hepatocytes oscillations induced by vasopressin were 
reversibly blocked by 20-30 PM diCy (data not shown). 
The solvents for diC, was ethanol, and for R 59 022 was 
DMSO; and they had no effect on phenylephrine or 
vasopressin-induced spiking, or alone, at concentra- 
tions added to the experimental medium: up to 0.25% 
(V/V) for ethanol, and up to 0.025% (V/V) for DMSO. 
4. DISCUSSION 
It has been shown that the DG-kinase inhibitor, R 59 
022, increases [%]DG and decreases [3ZP]phosphatidic 
acid levels in hepatocytes [12]. Thus, we can assume that 
R 59 022 inhibits DG-kinase in hepatocytes. The differ- 
ent sensitivities to R 59 022 of the free Ca oscillations 
induced by phenylephrine or vasopressin are compara- 
ble to those found in hepatocytes popu!ations for vaso- 
pressin and adrenaline on glycogen phosphorylase ac- 
tivity [12]. Different effects of R 59 022 have been re- 
ported on two DG-kinase isoenzymes 1161. It is possible 
that the differential sensitivity to R 59 022 of the free 
Ca responses to phenylephrine or vasnpressin are 
caused by these agonists coupling to different DG- 
kinase isoenzymcs. A further consideration isan unsub- 
stantiated suggcsrion that R 59 022 acts as a weak a,- 
adrenergic antagonist ill]. However, since R 59 022 
enhances rather than diminishes the increase in [“H]DG 
induced by adrenaline in hepatocytes [12], it is unlikely 
that the actions of R 59 022 are predominantly due to 
the displacement of the a,-agonist from its receptor. 
The DG analogue, diCs, has effects on free Ca oscil- 
lations that resemble those of R 59 022, as has been 
found in other ceii types [is]. Iiowever, in hepaiocyies, 
R 59 022 is mum effective on a molar basis than ex- 
ogcnously added synthetic DG. Also, free Ca oscilla- 
tions induced by vasopressin are less sensitive to diCs 
than those induced by phenylephrine, as has been 
shown for phorbol esters [9]. 
The DG-kinase inhibitor, R 59 022 [I 1,121, and diCI, 
both increase the level of endogenous DG, and will elicit 
an activation of PKC. The decrease in peak free Ca and 
in the frequency of the oscillations induced by both R 
59 022 and diCs supports the prediction that an en- 
hancement in PKC activity would diminish peak free Ca 
[l&19]. However, an increase in R 59 022 or diCs con- 
centration led to a blockade of the oscillations before 
a substantial reduction in peak free Ca was observed. 
Thus we are not yet confident hat these data provide 
convincing support for our Ireceptor controlled model’ 
of the hepatocytc alcium oscillator [18,19], in which 
transient generation of DG would activate PKC tran- 
siently. The reduction of free Ca oscillation frequency 
by R 59 022 or diC, could be explained by continuous 
phosphorylation of the hormone receptors by continu- 
ous activation of PKC [9,20]. Indeed, PKC inhibitors 
tend to raise the frequency of the free Ca oscillations 
when frequency is depressed by phorbol esters [lo]. A 
differential susceptibility of the a,-adrenergic and vaso- 
pressin receptors to negative feedback from PKC is our 
favoured explanation for the greater sensitivity of the 
phenylephrine-induced spiking to R 59 022 and diCs 
shown here. 
In summary, we show here that an increase in the 
level of endogenous DG, by inhibition of DG-kinase 
with R 59 022, or by adding DG exogenously as diCs. 
has similar inhibitory effects on free Ca oscillations to 
those produced by phorbol ester activators of PKC 
[9,10]. The data agree with the concept of negative feed- 
back being provided by PKC in the hepatocyte free Ca 
oscillator and, in particular, implicate endogenously 
generated DG in the mechanism. 
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